open access

Vol 1, No 4 (2005)
Review paper
Published online: 2005-12-12
Get Citation

Combined treatment of pancreatic cancer - current strategies

Tadeusz Popiela, Marek Sierżęga
Onkol. Prak. Klin 2005;1(4):183-191.

open access

Vol 1, No 4 (2005)
REVIEW ARTICLES
Published online: 2005-12-12

Abstract

Pancreatic cancer is one of the most common causes of cancer-related death. The prognosis, as indicated by nearly equal incidence and mortality rates, is very poor. Although the only chance for cure is currently pancreatic resection, the tumour can be removed only in about 20-30% of patients. Five-year survival rates reported in recent decades have demonstrated an increasing trend, but the 5-year survival is still only about 10-30% with the median survival of 15-20 months. A rising number of pancreatic resections along with centralisation of pancreatic cancer surgery in hospitals with adequately trained personnel resulted in reduced rates of morbidity and postoperative mortality. Previous clinical trials have emphasised the need for a combined treatment where chemotherapy or chemoradiotherapy are inseparably associated with surgical interventions. Though many enthusiastic studies have been reported, the optimal regimen of the combined therapy has not been agreed. Moreover, the differences observed between individual studies suggest that further well-designed clinical trials involving large patient populations are necessary.

Abstract

Pancreatic cancer is one of the most common causes of cancer-related death. The prognosis, as indicated by nearly equal incidence and mortality rates, is very poor. Although the only chance for cure is currently pancreatic resection, the tumour can be removed only in about 20-30% of patients. Five-year survival rates reported in recent decades have demonstrated an increasing trend, but the 5-year survival is still only about 10-30% with the median survival of 15-20 months. A rising number of pancreatic resections along with centralisation of pancreatic cancer surgery in hospitals with adequately trained personnel resulted in reduced rates of morbidity and postoperative mortality. Previous clinical trials have emphasised the need for a combined treatment where chemotherapy or chemoradiotherapy are inseparably associated with surgical interventions. Though many enthusiastic studies have been reported, the optimal regimen of the combined therapy has not been agreed. Moreover, the differences observed between individual studies suggest that further well-designed clinical trials involving large patient populations are necessary.
Get Citation

Keywords

pancreatic cancer; combined therapy; chemotherapy; radiotherapy

About this article
Title

Combined treatment of pancreatic cancer - current strategies

Journal

Oncology in Clinical Practice

Issue

Vol 1, No 4 (2005)

Article type

Review paper

Pages

183-191

Published online

2005-12-12

Bibliographic record

Onkol. Prak. Klin 2005;1(4):183-191.

Keywords

pancreatic cancer
combined therapy
chemotherapy
radiotherapy

Authors

Tadeusz Popiela
Marek Sierżęga

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl